Kalbe Farma Tbk PT
OTC:PTKFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalbe Farma Tbk PT
OTC:PTKFF
|
ID |
|
Paramount Global
F:0VVB
|
US |
|
A
|
Admiral Group PLC
F:FLN
|
UK |
|
V
|
Viscofan SA
DUS:VIS
|
ES |
|
E
|
EOG Resources Inc
XBER:EO5
|
US |
|
Spartan Delta Corp
TSX:SDE
|
CA |
|
P
|
PLDT Inc
OTC:PHTCF
|
PH |
|
U
|
Unisys Corp
F:USY1
|
US |
|
Boeing Co
LSE:0BOE
|
US |
|
Sunoco LP
NYSE:SUN
|
US |
|
S
|
Surf Air Mobility Inc
NYSE:SRFM
|
US |
|
I
|
Illumina Inc
XBER:ILU
|
US |
|
F
|
Fastly Inc
F:2Y7
|
US |
|
Sportradar Group AG
NASDAQ:SRAD
|
CH |
|
Intershop Holding AG
F:ISZN
|
CH |
|
Roebuck Food Group PLC
LSE:RFG
|
UK |
|
A
|
Ajinomoto Co Inc
DUS:AJI
|
JP |
|
Comer Industries SpA
F:X5Q
|
IT |
|
Legrand SA
LSE:0MW7
|
FR |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
Rolls-Royce Holdings PLC
LSE:RR
|
UK |
|
Wealth Minerals Ltd
XTSX:WML
|
CA |
|
F
|
Fujikura Ltd
SWB:FJK
|
JP |
|
B
|
Bper Banca SpA
DUS:4BE
|
IT |
Bankruptcy Probability
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kalbe Farma Tbk PT Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ID |
|
Kalbe Farma Tbk PT
IDX:KLBF
|
36.2T IDR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
625.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
322.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
252.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kalbe Farma Tbk PT has total debt of 282.3B IDR. This includes both short-term (110.4B IDR) and long-term (171.9B IDR) debt.
You can find a full breakdown on its Balance Sheet.
